DJIA 17,702.09 -43.89 -0.25%
NASDAQ 5,137.26 8.47 0.17%
S&P 500 2,107.16 -1.47 -0.07%
market minute promo

ZIOPHARM Oncology (NASDAQ: ZIOP)

13.15 0.25 (1.94%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ZIOP $13.15 1.94%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $12.88
Previous Close $12.90
Daily Range $12.80 - $13.06
52-Week Range $2.31 - $14.40
Market Cap $1.7B
P/E Ratio -14.33
Dividend (Yield) $0.00 (0.0%)
Volume 94,734
Average Daily Volume 3,508,929
Current FY EPS -$0.43

Sector

Healthcare

Industry

Drug Makers

ZIOPHARM Oncology (ZIOP) Description

ZIOPHARM Oncology Inc. is a biopharmaceutical company engaged in the development and commercialization of small molecule and synthetic biology approaches to new cancer therapies. Website: http://www.ziopharm.com/

News & Commentary Rss Feed

How the Rumor Mill Pumped Up Ziopharm Oncology's Valuation in June

Could a buyout be on the horizon for ZIOPHARM Oncology? That's what one columnist suggested in June. Find out whether or not you should consider buying into this bullishness or keep your distance.

ZIOPHARM Oncology (ZIOP) Flagged As Strong On High Volume

3 Biotech Stocks Working On CAR-T Immunotherapy You Ought To Watch

Juno Therapeutics, Kite Pharma, and Ziopharm Oncology are developing an entirely new way to battle cancer.

First Week of ZIOP August 21st Options Trading

Weighing The Week Ahead: Will Fedspeak Interrupt The Lazy-Hazy-Crazy Days Of Summer?

Several Biotech Stocks Indicating A Macro Short Strategy

Trade-Ideas: ZIOPHARM Oncology (ZIOP) Is Today's Post-Market Leader Stock

Intrexon Corp is expanding its business

Intrexon Corp is expanding his business

CAR T-Cell Stocks a Better Way to Leverage Biotech Than New 3x ETFs

See More ZIOP News...

ZIOP's Top Competitors

ZIOP $13.15 (1.94%)
Current stock: ZIOP
AMGN $179.50 (4.55%)
Current stock: AMGN
GILD $117.49 (-0.35%)
Current stock: GILD
BIIB $314.42 (-0.81%)
Current stock: BIIB